Supplemental Digital Content is Available in the Text.
Dr. Dokucu is Assistant Professor of Psychiatry, and Ms. DeNunzio is Research Project Coordinator, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, 710 North Lake Shore Dr, Abbott Hall Room 1324, Chicago, IL 60611, E-mail: email@example.com; and Mr. Essen is an MD/PhD candidate, Hacettepe University, Ankara, Turkey.
All faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations related to this CME activity. The authors have disclosed that the U.S. Food and Drug Administration has not approved the use of transcranial magnetic stimulation for the treatment of anxiety disorders as discussed in this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the newsletter's website (www.psychopharmrev.com).
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on January 31, 2014.